Assunta Imperato

Title: Assunta Imperato: Innovator in Parkinson's Disease Treatment

Introduction

Assunta Imperato is a notable inventor based in Paris, France, recognized for her contributions to the field of medical science, particularly in the treatment of Parkinson's disease. With a total of four patents to her name, she has made significant strides in developing innovative therapies that aim to improve the quality of life for patients suffering from neurological disorders.

Latest Patents

Among her latest patents is a groundbreaking combination of riluzole and levodopa for the treatment of Parkinson's disease. This invention focuses on the use of these compounds, or their pharmaceutically acceptable salts, to effectively treat the symptoms of this debilitating condition. Another significant patent involves the use of 2-amino-6-trifluoromethoxybenzothiazole for the prevention or treatment of cerebellar dysfunction. This method specifically targets cerebellar ataxia, utilizing riluzole or its pharmaceutically acceptable salts to provide therapeutic benefits.

Career Highlights

Throughout her career, Assunta has worked with prominent companies in the pharmaceutical industry, including Aventis Pharma S.A. and Rhône-Poulenc Rorer S.A. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to the advancement of medical treatments.

Collaborations

Assunta has had the opportunity to work alongside esteemed colleagues such as Andrees Bohme and Véronique Blanchard-Bregeon, who have played a vital role in her research and development efforts.

Conclusion

Assunta Imperato's innovative work in the treatment of Parkinson's disease exemplifies her dedication to improving patient outcomes through scientific research and collaboration. Her patents reflect a commitment to advancing medical knowledge and providing new solutions for those affected by neurological disorders.